News
CDIO
0.9560
+9.38%
0.0820
Weekly Report: what happened at CDIO last week (1223-1227)?
Weekly Report · 12/30/2024 11:09
Top 5 Biotech Stocks Dominating Retail Investor Conversations In 2024
Barchart · 12/26/2024 11:54
Weekly Report: what happened at CDIO last week (1216-1220)?
Weekly Report · 12/23/2024 11:16
Cardio Diagnostics:Precision, Epi+Gen CHD tests get CMS pricing determinations
TipRanks · 12/16/2024 13:40
Cardio Diagnostics Holdings Receives Final Medicare Pricing Determination From Centers For Medicare And Medicaid Services
Benzinga · 12/16/2024 13:35
CARDIO DIAGNOSTICS HOLDINGS: MEDICARE CONTRACTORS WILL REPORT TO CMS PRELIMINARY GAPFILL PRICING FOR CALENDAR YEAR 2025 BY APRIL 1, 2025
Reuters · 12/16/2024 13:31
Weekly Report: what happened at CDIO last week (1209-1213)?
Weekly Report · 12/16/2024 11:17
Weekly Report: what happened at CDIO last week (1202-1206)?
Weekly Report · 12/09/2024 11:15
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 12/06/2024 21:06
Cardio Diagnostics Non-Compliant With Nasdaq Minimum Bid Price Rule; Faces Delisting If Still Non-Compliant By June 2, 2025
Benzinga · 12/04/2024 21:50
CARDIO DIAGNOSTICS HOLDINGS INC - FACES DELISTING IF NON-COMPLIANT BY JUNE 2, 2025
Reuters · 12/04/2024 21:40
Weekly Report: what happened at CDIO last week (1125-1129)?
Weekly Report · 12/02/2024 11:16
Weekly Report: what happened at CDIO last week (1118-1122)?
Weekly Report · 11/25/2024 11:08
Weekly Report: what happened at CDIO last week (1111-1115)?
Weekly Report · 11/18/2024 11:05
Based on the provided financial report articles, I generated the title for the article: "CDIO's Quarterly Financial Report for Q3 2024: Common Stock, Additional Paid-in Capital, and Retained Earnings" Please note that the title may not be exact, as the provided text appears to be a financial report with various sections and data, and the title may not be explicitly stated.
Press release · 11/14/2024 00:23
Based on the provided financial report articles, I generated the title for the article: "CDIO's Quarterly Financial Report for Q3 2024: Common Stock, Additional Paid-in Capital, and Retained Earnings" Please note that the title is generated based on the content provided, and it may not be the exact title used in the original report.
Press release · 11/14/2024 00:22
Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference
Barchart · 11/12/2024 07:31
Weekly Report: what happened at CDIO last week (1104-1108)?
Weekly Report · 11/11/2024 11:17
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 11/06/2024 16:34
Weekly Report: what happened at CDIO last week (1028-1101)?
Weekly Report · 11/04/2024 11:15
More
Webull provides a variety of real-time CDIO stock news. You can receive the latest news about Cardio Diagnostics Holdings Inc through multiple platforms. This information may help you make smarter investment decisions.
About CDIO
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.